Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
RMD Open|September 12, 2022
Reactive arthritis after SARS-CoV-2 infectionSophia Dombret, Alla Skapenko, Hendrik Schulze-KoopsClinical Journal of Gastroenterology|December 7, 2023
Colitis induced by IL-17A-inhibitorsLea Grümme, Sophia Dombret, Thomas Knösel, et al.Methods in Molecular Medicine|November 7, 2007
Analysis of Th1/Th2 T-cell subsetsAlla Skapenko, Hendrik Schulze-KoopsRheumatology (Oxford, England)|September 15, 2017
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithmHendrik Schulze-Koops, Alla SkapenkoExpert Opinion on Biological Therapy|October 22, 2002
Immunosuppression with biologicals: prospects for the treatment of autoimmune diseasesHendrik Schulze-Koops, Alla SkapenkoNature Reviews. Rheumatology|November 2, 2010
Inflammation: TREG cell control of autoimmune inflammation: a matter of timing?Hendrik Schulze-Koops, Alla SkapenkoNature Reviews. Rheumatology|July 29, 2009
Prognostic factors in rheumatoid arthritis in the era of biologic agentsAlla Skapenko, Iryna Prots, Hendrik Schulze-KoopsRMD Open|February 25, 2021
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccinesHendrik Schulze-Koops, Christof Specker, Alla SkapenkoRheumatology (Oxford, England)|February 8, 2020
Altered T cell plasticity favours Th17 cells in early arthritisJan Leipe, Fausto Pirronello, Hendrik Schulze-Koops, et al.RMD Open|February 22, 2023
A rare side effect of methotrexate therapy: drug-induced osteopathy with multiple fractures of the lower limbDelila Singh, Nina Hesse, Alla Skapenko, et al.Pageof 19